Therapeutic Fraud Prevention Act

The Therapeutic Fraud Prevention Act amends the Federal Trade Commission Act to clarify that providing conversion therapy to any person in exchange for monetary compensation or advertising such services is an unfair or deceptive act or practice.


H.R 4146; S. 2242

What is the Therapeutic Fraud Prevention Act?

The Therapeutic Fraud Prevention Act would officially classify the provision and advertising of conversion therapy in exchange for monetary compensation as fraudulent practices. While the Federal Trade Commission (FTC) already has the authority to prohibit this form of consumer fraud, the Therapeutic Fraud Prevention Act would expressly direct the FTC to protect consumers from these harmful and discredited practices.

The FTC exists “to protect consumers by preventing […] deceptive and unfair business practices.” Conversion therapy providers engage in misleading and deceptive practices based on the false and discredited belief that one’s sexual orientation and gender identity can be changed, resulting in tremendous harm to consumers.

What is the Current Status of the Bill?

The Therapeutic Fraud Prevention Act was introduced in the House of Representatives by Rep. Ted Lieu (D-CA) and in the Senate by Sens. Patty Murray (D-WA) and Cory Booker (D-NJ) on June 24, 2021.

Last updated May 23, 2022

Related Resources

View AllRelated Resources